---
title: "Hua Medicine Warns on Profit as Wanka Online Raises HKD 350 Million for AI Push"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296333601.md"
description: "A mixed bag of corporate updates shows Hua Medicine expecting a first-half loss despite new drug approvals, while Wanka Online secures fresh capital. BOE Varitronix faces earnings compression."
datetime: "2026-08-19T09:43:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296333601.md)
  - [en](https://longbridge.com/en/news/296333601.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296333601.md)
generator: "portal-rs"
---

# Hua Medicine Warns on Profit as Wanka Online Raises HKD 350 Million for AI Push

Divergent fundamentals are shaping the recent trajectory of several Hong Kong-listed equities, spanning clinical biotech to hardware manufacturing and traditional financial services. Wanka Online (1762.HK) moved aggressively on capital raising, announcing a share placement in March 2026 to secure approximately HKD 350 million. The advertising agency plans to deploy 60% of the proceeds toward M&A and 30% into AI and overseas expansion.

In the biopharma space, Hua Medicine (2552.HK) is bracing for a turbulent first half. Despite securing Hong Kong approval for its innovative diabetes drug in March 2026, the company expects to swing to a loss for the period, setting a cautious tone ahead of its August earnings report. Meanwhile, Transcenta Holding (6628.HK) continues its R&D grind, advancing clinical trials for its suite of oncology antibodies, including combinations with Opdivo.

Hardware makers are seeing margin compression. BOE Varitronix (0710.HK), the sole automotive display platform for BOE Technology Group, reported full-year 2025 revenue of HKD 14 billion—a 3.8% increase—yet saw its EPS drop to HKD 0.44. In asset management, China Everbright Holdings (0165.HK) maintained a vast portfolio, closing 2025 with HKD 121.4 billion in assets under management across 71 funds.

Consumer and industrial stalwarts are leaning on core operations. 361 Degrees (0361.HK) is leveraging sports sponsorships, locking in official partnerships for the 2026 Asian Games to drive mass-market apparel sales. China Reinsurance (1508.HK) posted 2025 revenue of 107.92 billion yuan, up 4.11%, but saw profits slide by 7.44%. Sinofert (0297.HK) advanced its scheduled dividend payouts for the summer of 2026. Lastly, heavyweights like China Construction Bank (1939.HK) and Shenzhou International (0580.HK) remain fundamental pillars in their respective sectors amid broader market fluctuations.

### Related Stocks

- [01762.HK](https://longbridge.com/en/quote/01762.HK.md)
- [02552.HK](https://longbridge.com/en/quote/02552.HK.md)
- [06628.HK](https://longbridge.com/en/quote/06628.HK.md)
- [01508.HK](https://longbridge.com/en/quote/01508.HK.md)
- [01939.HK](https://longbridge.com/en/quote/01939.HK.md)

## Related News & Research

- [UBS Sticks to Its Buy Rating for China Reinsurance (Group) Corp. Class H (C53)](https://longbridge.com/en/news/297574105.md)
- [Shangshan Gold Sets Out Board and Committee Structure](https://longbridge.com/en/news/297503394.md)
- [Transcenta HY26 net loss narrows to RMB 67.35 million; revenue more than doubled to RMB 23.6 million](https://longbridge.com/en/news/297332015.md)
- [Transcenta files list of directors, board committee roles and disclosure-responsible management](https://longbridge.com/en/news/297344237.md)
- [Transcenta Calls Extraordinary Meeting to Approve Asset Purchase Deal](https://longbridge.com/en/news/296836138.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**